LIM kinase function and renal growth: Potential role for LIM kinases in fetal programming of kidney development

Alexander J Sparrow1, Dylan Sweetman2, Simon J M Welham3

  • 1Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, West Wing, John Radcliffe Hospital, Oxford OX3 9DU, UK.

Life Sciences
|August 5, 2017
PubMed
Abstract

Insights

Inhibiting LIM-kinase in developing kidneys blocks nephron formation by disrupting cell division. This finding reveals a critical role for LIM-kinase in early kidney development and offers insights into developmental defects.

Area of Science:

  • Developmental Biology
  • Nephrology
  • Molecular Biology

Background:

  • Maternal dietary restriction during pregnancy is known to impair fetal kidney development, leading to reduced nephron numbers.
  • Cell turnover in the developing kidney is sensitive to maternal nutrition and may involve regulation by LIM-kinase enzymes.

Purpose of the Study:

  • To investigate the role of LIM-kinase activity in nephron formation during early kidney development.
  • To determine if inhibiting LIM-kinase function contributes to impaired nephrogenesis.

Main Methods:

  • Cultured E12.5 metanephric kidneys and HK2 cells were treated with BMS5, a pharmacological LIM-kinase inhibitor.
  • Cell proliferation and mitosis were assessed using DiI labeling and pH3 staining.
  • Organ growth and cell migration were quantified over 48 hours.

Main Results:

  • BMS5 treatment significantly reduced kidney growth and final cell numbers.
  • While mitosis occurred, BMS5 severely impaired the completion of anaphase, indicating defects in mitotic spindle function.
  • Cell migration was completely blocked, and nephrogenic precursor cells were depleted, halting new nephron formation.

Conclusions:

  • Pharmacological inhibition of LIM-kinase activity severely disrupts early kidney development.
  • LIM-kinase is essential for successful completion of mitosis and cell migration during nephrogenesis.
  • Disruption of LIM-kinase function leads to a failure in renal development, likely due to mitotic errors and cell loss.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.8K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
15.3K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
8.8K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
18.7K